PL3452829T3 - Perm jako marker raka trzonu macicy - Google Patents

Perm jako marker raka trzonu macicy

Info

Publication number
PL3452829T3
PL3452829T3 PL17713973.0T PL17713973T PL3452829T3 PL 3452829 T3 PL3452829 T3 PL 3452829T3 PL 17713973 T PL17713973 T PL 17713973T PL 3452829 T3 PL3452829 T3 PL 3452829T3
Authority
PL
Poland
Prior art keywords
perm
marker
uterine body
body cancer
cancer
Prior art date
Application number
PL17713973.0T
Other languages
English (en)
Polish (pl)
Inventor
Elena MARTINEZ GARCÍA
Eva COLÁS ORTEGA
Antonio Gil Moreno
Jaume REVENTÓS PUIGJANER
Bruno Domon
Antoine LESUR
Original Assignee
Fundació Hospital Universitari Vall D'hebron - Institut De Recerca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundació Hospital Universitari Vall D'hebron - Institut De Recerca filed Critical Fundació Hospital Universitari Vall D'hebron - Institut De Recerca
Publication of PL3452829T3 publication Critical patent/PL3452829T3/pl

Links

Classifications

    • G01N33/5755
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/902Oxidoreductases (1.)
    • G01N2333/908Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486Metalloendopeptidases (3.4.24)
    • G01N2333/96491Metalloendopeptidases (3.4.24) with definite EC number
    • G01N2333/96494Matrix metalloproteases, e. g. 3.4.24.7
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
PL17713973.0T 2016-05-04 2017-03-30 Perm jako marker raka trzonu macicy PL3452829T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16168328 2016-05-04
PCT/EP2017/057635 WO2017190896A1 (en) 2016-05-04 2017-03-30 Mmp9 as marker of endometrial cancer

Publications (1)

Publication Number Publication Date
PL3452829T3 true PL3452829T3 (pl) 2024-05-20

Family

ID=56096908

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17713973.0T PL3452829T3 (pl) 2016-05-04 2017-03-30 Perm jako marker raka trzonu macicy

Country Status (11)

Country Link
US (2) US20190137499A1 (enExample)
EP (3) EP4610655A3 (enExample)
JP (3) JP7240712B2 (enExample)
AU (3) AU2017260806B9 (enExample)
CA (2) CA3286798A1 (enExample)
DK (1) DK3452829T3 (enExample)
ES (1) ES2974307T3 (enExample)
FI (1) FI3452829T3 (enExample)
PL (1) PL3452829T3 (enExample)
PT (1) PT3452829T (enExample)
WO (1) WO2017190896A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018303249B2 (en) * 2017-07-21 2025-02-27 Fundació Hospital Universitari Vall D'hebron - Institut De Recerca Markers for endometrial cancer
EP4373973A1 (en) * 2021-07-23 2024-05-29 Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca Biomarkers for endometrial cancer
CN113493838B (zh) * 2021-09-06 2021-11-23 北京泱深生物信息技术有限公司 子宫内膜癌相关的标志分子及其在诊断子宫内膜癌中的应用
KR102640230B1 (ko) * 2021-09-24 2024-02-22 가천대학교 산학협력단 C-peptide를 처리한 자궁내막 기질세포의 이동성 변화 기작을 이용한 자궁내막 관련질환의 진단 방법 및 자궁내막 관련질환 치료제의 스크리닝 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
AUPO573697A0 (en) * 1997-03-20 1997-04-10 Prince Henry's Institute Of Medical Research Diagnosis of endometrial cancer
US20080226554A1 (en) 2003-12-23 2008-09-18 Mount Sinai Hospital Methods For Detecting Markers Associated With Endometrial Disease or Phase
WO2008003024A2 (en) * 2006-06-28 2008-01-03 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Method and composition for diagnosing endometrial cancer
WO2008049239A1 (en) 2006-10-27 2008-05-02 Mount Sinai Hospital Endometrial biomarkers
JP5934093B2 (ja) * 2009-07-24 2016-06-15 ジアディック・バイオテック・アグルパシオン・デ・インテレス・エコノミコGeadic Biotec, Aie. 子宮内膜がんのマーカー

Also Published As

Publication number Publication date
AU2025223935A1 (en) 2025-09-18
BR112018072498A2 (pt) 2019-03-12
EP3452829B1 (en) 2024-01-24
WO2017190896A1 (en) 2017-11-09
US20190137499A1 (en) 2019-05-09
EP4180814A3 (en) 2023-07-12
AU2023210591A1 (en) 2023-08-24
AU2023210591B9 (en) 2025-07-10
DK3452829T3 (da) 2024-03-25
EP3452829A1 (en) 2019-03-13
EP4180814A2 (en) 2023-05-17
JP2023040246A (ja) 2023-03-22
JP7240712B2 (ja) 2023-03-16
AU2017260806A1 (en) 2018-12-13
AU2017260806B2 (en) 2023-06-15
PT3452829T (pt) 2024-03-22
EP4610655A3 (en) 2025-12-10
JP2024116127A (ja) 2024-08-27
EP4610655A2 (en) 2025-09-03
JP7797770B2 (ja) 2026-01-14
FI3452829T3 (fi) 2024-03-20
ES2974307T3 (es) 2024-06-26
JP2019516104A (ja) 2019-06-13
CA3022586A1 (en) 2017-11-09
JP7492287B2 (ja) 2024-05-29
CA3286798A1 (en) 2025-10-30
AU2017260806B9 (en) 2023-07-20
US20230221323A1 (en) 2023-07-13
AU2023210591B2 (en) 2025-06-26

Similar Documents

Publication Publication Date Title
IL261468A (en) Uterine cancer treatments
IL269026A (en) Methods of treating tumor
IL264023A (en) Nant cancer vaccine
DK3206678T3 (da) Kropsformning
MA41117A (fr) Imagerie d'un corps
PL3283527T3 (pl) Leczenie skojarzone nowotworów
HUE059694T2 (hu) Készítmény rák kezelésére
HUE046505T2 (hu) Antitestkészítmények daganatkezelésre
CL2017000934S1 (es) Cartucho secuenciador
DK3107487T3 (da) Kropsimplantater til blødt væv
IL263802A (en) Cancer treatment combinations
HUE053744T2 (hu) A rák kombinált kezelése
IL284875A (en) Lasofoxifene treatment of breast cancer
EP3878406C0 (en) DIRECTIONAL TISSUE EXPANDER
EP3413927A4 (en) CANCER THERAPY
EP3531991C0 (en) WHOLE BODY HYPERTHERMIA SYSTEM
LT3576740T (lt) Vėžio gydymas
EP3593139C0 (en) CANCER BIOMARKERS
EP3456292A4 (en) FABRIC BODY FORMING DEVICE
EP3572715A4 (en) LIGHTING DEVICE
HUE053648T2 (hu) Gyógyászati kombinációk rák kezelésére
EP3731763A4 (en) GENERIC SURGICAL NAVIGATION INTERFACE
EP3725558A4 (en) ORNAMENTAL BODY
IL264277A (en) Crebbp related cancer therapy
PL3452829T3 (pl) Perm jako marker raka trzonu macicy